**Core Concept**
Pyrazinamide is a crucial antitubercular medication used in the treatment of tuberculosis (TB), particularly in the intensive phase. It acts by inhibiting fatty acid synthase I, an essential enzyme for the growth and survival of Mycobacterium tuberculosis.

**Why the Correct Answer is Right**
The correct answer is not explicitly provided, so I'll assume we're explaining the false statement among the options. However, since the correct answer is missing, I'll provide a general explanation. The mechanism of action of pyrazinamide involves the inhibition of fatty acid synthase I, an enzyme responsible for the synthesis of fatty acids in M. tuberculosis. This disruption of fatty acid synthesis ultimately leads to the death of the bacteria. Pyrazinamide's action is particularly effective in acidic environments, such as within the macrophages of the host.

**Why Each Wrong Option is Incorrect**
**Option A:** Pyrazinamide is effective against both intracellular and extracellular forms of M. tuberculosis. This statement is likely true and is not the false statement among the options.

**Option B:** Pyrazinamide is primarily used in the treatment of drug-resistant TB. This statement might be misleading, but it's not necessarily false, as pyrazinamide is used in various treatment regimens for TB, including drug-resistant cases.

**Option C:** Pyrazinamide's mechanism of action involves the inhibition of the cell wall synthesis of M. tuberculosis. This statement is false because pyrazinamide's primary mechanism of action is the inhibition of fatty acid synthase I, not cell wall synthesis. Cell wall synthesis is a target for other antitubercular medications, such as isoniazid.

**Clinical Pearl / High-Yield Fact**
Pyrazinamide is known to cause hepatotoxicity, particularly when used in combination with other medications like isoniazid. It's essential to monitor liver function tests regularly in patients taking pyrazinamide.

**Correct Answer:** None provided, but based on the explanation, **Option C** is the false statement regarding pyrazinamide.